Publications by authors named "C Pilarsky"
Objective: Pancreatic ductal adenocarcinoma (PDAC) stands as one of the most lethal cancers, marked by its lethality and limited treatment options, including the utilisation of checkpoint blockade (ICB) immunotherapy. Epigenetic dysregulation is a defining feature of tumourigenesis that is implicated in immune surveillance, but remains elusive in PDAC.
Design: To identify the factors that modulate immune surveillance, we employed epigenetic-focused CRISPR-Cas9 screen in mouse PDAC tumour models engrafted in either immunocompetent or immunodeficient mice.
Perturbation of cell polarity is a hallmark of pancreatic ductal adenocarcinoma (PDAC) progression. Scribble (SCRIB) is a well-characterized polarity regulator that has diverse roles in the pathogenesis of human neoplasms. To investigate the impact of SCRIB deficiency in PDAC development and progression, Scrib expression was genetically ablated in well-established mouse models of PDAC.
View Article and Find Full Text PDFArticle Synopsis
- Pancreatic cancer is hard to treat because it's often diagnosed at an advanced stage, lacks early symptoms, and has few reliable biomarkers for detection.
- *Recent research shows that interactions between cancer and immune cells in both the tumor micro-environment and distant areas of the body (macro-environment) play a crucial role in tumor growth and immune response.
- *Understanding how these environments interact may lead to new early detection methods and therapies for pancreatic cancer through identifying molecular targets and improving diagnostic biomarkers.
Interleukin (IL)-3 has long been known for its hematopoietic properties. However, recent evidence has expanded our understanding of IL-3 function by identifying IL-3 as a critical orchestrator of inflammation in a wide array of diseases. Depending on the type of disease, the course of inflammation, the cell or the tissue involved, IL-3 promotes either pathologic inflammation or its resolution.
View Article and Find Full Text PDFPancreatic cancer is a malignant tumor of the digestive system. It is highly aggressive, easily metastasizes, and extremely difficult to treat. This study aimed to analyze the genes that might regulate pancreatic cancer migration to provide an essential basis for the prognostic assessment of pancreatic cancer and individualized treatment.
View Article and Find Full Text PDF